TrialInflammatory bowel diseases2022

Predictors of Sustained Response With Tofacitinib Therapy in Patients With Ulcerative Colitis.

William J Sandborn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.